Literature DB >> 21878323

Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis.

Souleiman El Balkhi1, Jean-Marc Trocello, Joël Poupon, Philippe Chappuis, France Massicot, Nadège Girardot-Tinant, France Woimant.   

Abstract

Wilson disease (WD) is an autosomal recessive inherited disorder of copper metabolism. Failure to diagnose WD can be dramatic leading to irreversible damages. The molecular genetic analysis of ATP7B gene is the reference test for diagnosis but the number of reported mutations of the ATP7B gene is on the rise. The analysis is cumbersome and requires tedious work. Other clinical and biological tests are proposed but it is often difficult to interpret some patients' results. A rapid and reliable biological test for WD diagnosis is still needed. Analytical reliability of Exchangeable copper (CuEXC) determination procedure is examined by studying the repeatability, the short term stability and stability in frozen serum. Relative exchangeable copper (REC=CuEXC/total copper%) is proposed and evaluated as a new diagnostic test and compared to classic tests used for WD diagnosis. Sixteen new Wilson disease patients were diagnosed in our institution between January 2009 and May 2011. The different biological tests used for WD diagnosis yielded lower sensitivity and specificity compared to our new biomarker, the REC. We show that REC is an excellent discriminatory tool for the diagnosis of WD offering 100% sensitivity and 100% specificity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878323     DOI: 10.1016/j.cca.2011.08.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.

Authors:  Karolina Dzieżyc; Tomasz Litwin; Grzegorz Chabik; Anna Członkowska
Journal:  Funct Neurol       Date:  2015 Oct-Dec

Review 2.  Update on the Diagnosis and Management of Wilson Disease.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2018-11-05

Review 3.  Challenges in the diagnosis of Wilson disease.

Authors:  Aurélia Poujois; France Woimant
Journal:  Ann Transl Med       Date:  2019-04

Review 4.  New tools for Wilson's disease diagnosis: exchangeable copper fraction.

Authors:  France Woimant; Nouzha Djebrani-Oussedik; Aurélia Poujois
Journal:  Ann Transl Med       Date:  2019-04

Review 5.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

6.  Novel mutations of the ATP7B gene in Han Chinese families with pre-symptomatic Wilson's disease.

Authors:  Zhe-Feng Yuan; Wei Wu; Yong-Lin Yu; Jue Shen; Shan-Shan Mao; Feng Gao; Zhe-Zhi Xia
Journal:  World J Pediatr       Date:  2015-08-08       Impact factor: 2.764

7.  Biomarkers for diagnosis of Wilson's disease.

Authors:  Aidan Ryan; Sarah J Nevitt; Orla Tuohy; Paul Cook
Journal:  Cochrane Database Syst Rev       Date:  2019-11-19

8.  Evolution of exchangeable copper and relative exchangeable copper through the course of Wilson's disease in the Long Evans Cinnamon rat.

Authors:  Françoise Schmitt; Guillaume Podevin; Joël Poupon; Jérôme Roux; Pierre Legras; Jean-Marc Trocello; France Woimant; Olivier Laprévote; Tuan Huy Nguyen; Souleiman El Balkhi
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

Review 9.  Bioavailable Trace Metals in Neurological Diseases.

Authors:  Aurélia Poujois; Jean-Christophe Devedjian; Caroline Moreau; David Devos; Pascal Chaine; France Woimant; James A Duce
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

10.  A PrP(C)-caveolin-Lyn complex negatively controls neuronal GSK3β and serotonin 1B receptor.

Authors:  Julia Hernandez-Rapp; Séverine Martin-Lannerée; Théo Z Hirsch; Elodie Pradines; Aurélie Alleaume-Butaux; Benoît Schneider; Anne Baudry; Jean-Marie Launay; Sophie Mouillet-Richard
Journal:  Sci Rep       Date:  2014-05-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.